Clinical

Dataset Information

0

A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC


ABSTRACT: The purpose of this study to assess efficacy and tolerability of combination therapy FOLFOXIRI with Bevacizumab (BV) as a first-line therapy in patients with metastatic colorectal cancer.

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2174842 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2629147 | ecrin-mdr-crc
| S-EPMC4102952 | biostudies-literature
| S-EPMC3078596 | biostudies-literature
| S-EPMC7376863 | biostudies-literature
| 2316883 | ecrin-mdr-crc
| 2312043 | ecrin-mdr-crc
| S-EPMC5814264 | biostudies-literature
| 2165831 | ecrin-mdr-crc
| S-EPMC5617509 | biostudies-literature
| S-EPMC8514824 | biostudies-literature